DB16919ApprovedWithdrawnVaccines
Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (propiolactone inactivated) is a component of an inactivated influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that helps to protect against infection from influenza viruses.
- First approval
- United States, 2022
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of August 04, 2026
Which companies are running trials of Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (propiolactone inactivated), in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account